SEC Form 4 · accession 0001645627-17-000037
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 17, 2017
Accepted (ET)
Apr 19, 2017 · 9:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.052 | A | 20,206,849 | D | |
| Common Stock | Apr 17, 2017 | P | 1,000 | $0.0499 | A | 20,207,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.055 | A | 20,208,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.0549 | A | 20,209,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.055 | A | 20,210,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.055 | A | 20,211,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.055 | A | 20,212,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.059 | A | 20,213,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.0595 | A | 20,214,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.648 | A | 20,215,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.06 | A | 20,216,849 | D | |
| Common Stock | Apr 18, 2017 | P | 1,000 | $0.0647 | A | 20,217,849 | D |
Table II — derivative securities
No Table II lines on this filing.